Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center

Multidisciplinary Care for a Patient With Metastatic HER2+ Breast Cancer

September 8th 2021

An overview of optimal multidisciplinary care for a patient who presents with HER2+ metastatic breast cancer.

Challenges in the Multidisciplinary Management of Breast Cancer

September 8th 2021

Key opinion leaders highlight the challenges inherent in using multidisciplinary care to manage breast cancer, particularly when a patient is seen at multiple institutions.

Multidisciplinary Care in BC: How Best to Communicate Patient Information

September 1st 2021

Focusing on the value of electronic systems and tumor boards, experts detail how best to communicate across disciplines in the management of breast cancer.

Difference in Breast Cancer Outcomes With Multidisciplinary Care

September 1st 2021

Shared insight on how nuanced multidisciplinary care can positively impact outcomes when treating a patient with breast cancer.

Managing Breast Cancer: Collaboration Throughout the Treatment Journey

August 25th 2021

Comprehensive details on how multidisciplinary care is applied during a patient’s treatment journey, with a focus on pulmonology and critical care.

Managing Breast Cancer: Who’s Involved in Multidisciplinary Care?

August 25th 2021

Experts reflect on the importance of multidisciplinary care and outline the many disciplines involved in diagnosing and treating breast cancer.

Future Directions for Treatment of TNBC

October 23rd 2020

Phase 3 ASCENT Trial in mTNBC: Managing Adverse Events

October 23rd 2020

Phase 3 ASCENT Trial in mTNBC

October 23rd 2020

Sequencing Therapies for mTNBC

October 23rd 2020

Standard of Care for BRCA+ mTNBC

October 23rd 2020

Testing for PD-L1 Expression in mTNBC

October 23rd 2020

KEYNOTE-355 Trial in mTNBC

October 23rd 2020

Standard of Care for Metastatic TNBC

October 23rd 2020

Current Trials for Treatment of Early Stage TNBC

October 23rd 2020

Emerging Data on Biomarkers in ES TNBC

October 23rd 2020

ICI-Based Therapy in TNBC: Immune-Related Adverse Events

October 23rd 2020

Role of Immune Checkpoint Inhibitor-Based Therapy in ES TNBC

October 23rd 2020

Early Stage TNBC: Phase 3 IMpassion031 Study

October 23rd 2020

Key Trials in ICI-Based Therapy for Early Stage TNBC

October 23rd 2020